StockData
Gelteq Ltd logo

Gelteq Ltd (GELS) income statement

GELSNasdaqPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Jun 30, 2025Last filing: 20-F on Nov 16, 2026Score 0/30
$0.27+0.00 (+0.37%)

Close on Nov 18, 2026Market cap $2.89MP/E –Yield –

Gelteq Ltd income statement

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY2025

Gross margin
30.3%
Operating margin
-3317.7%
Net margin
–
Return on equity, FY2025
–

Financial strength

Current ratio
0.09
Debt to equity
–
Debt to assets
25.4%
Cash to current liabilities
0.2%

Valuation

P/E ratio
–
Price to sales
25.77
Price to book
–
Dividend yield
–

See a number that looks wrong?